NM_024513.4:c.1335G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024513.4(FYCO1):​c.1335G>A​(p.Leu445Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.188 in 1,614,032 control chromosomes in the GnomAD database, including 30,135 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2226 hom., cov: 32)
Exomes 𝑓: 0.19 ( 27909 hom. )

Consequence

FYCO1
NM_024513.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.103

Publications

22 publications found
Variant links:
Genes affected
FYCO1 (HGNC:14673): (FYVE and coiled-coil domain autophagy adaptor 1) The gene encodes a Rab7 adapter protein that is implicated in the microtubule transport of autophagosomes. The encoded protein contains a RUN domain, a FYVE-type zinc finger domain, and Golgi dynamics (GOLD) domain. The encoded protein plays a role in microtubule plus end-directed transport of autophagic vesicles through interactions with the small GTPase Rab7, phosphatidylinositol-3-phosphate (PI3P), the autophagosome marker LC3, and the kinesin KIF5. Mutations in this gene are associated with inclusion body myositis (IBM) and autosomal recessive congenital cataracts (CATC2). [provided by RefSeq, Aug 2020]
FYCO1 Gene-Disease associations (from GenCC):
  • cataract 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • total early-onset cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 3-45967999-C-T is Benign according to our data. Variant chr3-45967999-C-T is described in ClinVar as [Benign]. Clinvar id is 261719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.103 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.267 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FYCO1NM_024513.4 linkc.1335G>A p.Leu445Leu synonymous_variant Exon 8 of 18 ENST00000296137.7 NP_078789.2 Q9BQS8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FYCO1ENST00000296137.7 linkc.1335G>A p.Leu445Leu synonymous_variant Exon 8 of 18 1 NM_024513.4 ENSP00000296137.2 Q9BQS8-1

Frequencies

GnomAD3 genomes
AF:
0.158
AC:
23996
AN:
152042
Hom.:
2223
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0641
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.204
Gnomad EAS
AF:
0.279
Gnomad SAS
AF:
0.154
Gnomad FIN
AF:
0.168
Gnomad MID
AF:
0.242
Gnomad NFE
AF:
0.199
Gnomad OTH
AF:
0.192
GnomAD2 exomes
AF:
0.183
AC:
46021
AN:
251450
AF XY:
0.186
show subpopulations
Gnomad AFR exome
AF:
0.0604
Gnomad AMR exome
AF:
0.144
Gnomad ASJ exome
AF:
0.206
Gnomad EAS exome
AF:
0.285
Gnomad FIN exome
AF:
0.172
Gnomad NFE exome
AF:
0.203
Gnomad OTH exome
AF:
0.206
GnomAD4 exome
AF:
0.191
AC:
279749
AN:
1461872
Hom.:
27909
Cov.:
81
AF XY:
0.191
AC XY:
139213
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0586
AC:
1963
AN:
33480
American (AMR)
AF:
0.146
AC:
6545
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
5426
AN:
26136
East Asian (EAS)
AF:
0.298
AC:
11832
AN:
39700
South Asian (SAS)
AF:
0.155
AC:
13361
AN:
86258
European-Finnish (FIN)
AF:
0.180
AC:
9598
AN:
53408
Middle Eastern (MID)
AF:
0.239
AC:
1379
AN:
5768
European-Non Finnish (NFE)
AF:
0.196
AC:
218066
AN:
1112002
Other (OTH)
AF:
0.192
AC:
11579
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
15725
31450
47174
62899
78624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7542
15084
22626
30168
37710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.158
AC:
23997
AN:
152160
Hom.:
2226
Cov.:
32
AF XY:
0.157
AC XY:
11674
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0641
AC:
2661
AN:
41542
American (AMR)
AF:
0.170
AC:
2601
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.204
AC:
707
AN:
3470
East Asian (EAS)
AF:
0.279
AC:
1441
AN:
5156
South Asian (SAS)
AF:
0.154
AC:
741
AN:
4822
European-Finnish (FIN)
AF:
0.168
AC:
1778
AN:
10592
Middle Eastern (MID)
AF:
0.260
AC:
76
AN:
292
European-Non Finnish (NFE)
AF:
0.199
AC:
13548
AN:
67960
Other (OTH)
AF:
0.190
AC:
402
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
993
1985
2978
3970
4963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
1277
Bravo
AF:
0.159
Asia WGS
AF:
0.189
AC:
655
AN:
3478
EpiCase
AF:
0.208
EpiControl
AF:
0.202

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cataract 18 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.58
DANN
Benign
0.49
PhyloP100
0.10
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3796376; hg19: chr3-46009491; COSMIC: COSV56113661; API